Life Sciences Ontario
Life Sciences Ontario (LSO) strives to be the unified Voice of Life Sciences in Ontario by representing the interests of the diverse life sciences community in the province through advocacy, education, facilitation of economic development and promotion of the industry locally, nationally and internationally. Together we are a strong, innovative sector with significant socioeconomic contributions to the province of Ontario. We hope you will consider joining LSO and help us to achieve our vision for Ontario's life sciences sector - "Diversity of Members, Unity of Voice".
CloudDX makes final cut in $10M Tricoder XPrize contest
Tuesday, September 2, 2014
A tiny company from Mississauga, Ont., has made the final cut of companies competing to make a science fiction dream a reality and win the $10-million Qualcomm Tricorder XPrize. CloudDX is among 10 finalists for the 3-1/2-year-old prize, which aims to develop a consumer-focused, mobile device capable of diagnosing and interpreting a set of 15 medical conditions and capturing five vital health metrics.
Proteocyte Diagnostics initiates a Cost-Effectiveness Analysis with support from Mitacs
Tuesday, September 2, 2014
Proteocyte Diagnostics Inc. of Toronto announced their collaboration with Mitacs Accelerate to conduct an economic evaluation of its predictive technology for the early detection of oral cancer. Weve partnered with Mitacs before with great success, said Dr. Mario Thomas, Chief Commercialization Officer of Proteocyte Diagnostics. The intent of this study is to show the value for money of identifying oral cancer before it happens. We know that private payers and governments will want solid data supporting the value of Straticyte. This is a groundbreaking diagnostic test for early identification of oral cancers that has the potential to save lives, improve quality of life and reduce healthcare costs.
LSO and OBI co-host a networking event for members from across Ontario’s life science industry
Friday, August 22, 2014
On Wednesday, August 20th 2014, Life Sciences Ontario (LSO) and the Ontario Brain Institute (OBI) partnered to co-host a networking event that showcased the dynamism and depthof Ontarios life science sector. The event was held at Marche restaurant in Torontos financial district.
Ontario Genomics Institute Pre-commercialization Business Development Fund (PBDF)
Friday, August 15, 2014
GI's Pre-commercialization Business Development Fund (PBDF) is now open for another round of investment. The PBDF is an investment fund that enables the commercialization of omics/life sciences research and technology development. Specifically, it aims to provide early-stage funding as companies (on their own or with academic collaborators) move towards commercial applications, and speed up the transfer of products from lab to marketplace.